Pricing Log in Create free account
Friday 6 November 2026 Export GRAL’s income statement to Excel — free account

GRAIL, Inc.

GRAL Healthcare Diagnostics & Research

GRAIL, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $147.2 million, up 17.2% from fiscal 2024.

Revenue
+3.71%
EPS
+10.2%
Free cash flow
−24.9%

Quarter to September 2026, against a year earlier

119.26 0.13 +0.11%
Market cap
$5.3B
P/E
0.0×
Fwd P/E
−14.5×
Dividend yield
—
F-score
6/9
Altman Z
0.37
Beneish M
n/a
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

GRAIL, Inc. (GRAL) Operating cash flow

Alert me on Operating cash flow

GRAIL, Inc.'s operating cash flow for fiscal 2025 was −$299.0M, compared with −$577.2M in fiscal 2024. Over the twelve months to 30 September 2026 it was −$306.2M. GRAIL, Inc. ranks 49th of 49 Diagnostics & Research companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2025 −$299.0M —
FY2024 −$577.2M —
FY2023 −$595.8M —
FY2022 −$561.3M —

Quarterly newest first

Period Operating cash flow Change
Sep 2026 −$74.7M —
Jun 2026 −$80.7M —
Mar 2026 −$87.0M —
Dec 2025 −$63.8M —
11 more quarters

Operating cash flow against peers

Company Operating cash flow
ICLR ICON PLC compare $1.0B
QGEN QIAGEN N.V. compare $654.5M
SHC Sotera Health Company compare $331.6M
RDNT RadNet, Inc. compare $310.1M
VCYT Veracyte, Inc. compare $173.9M
CDNA CareDx, Inc. compare $69.0M
BLLN BillionToOne, Inc. compare $47.9M
ADPT Adaptive Biotechnologies Corporation compare −$4.3M
GRAL GRAIL, Inc. −$306.2M

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on GRAL